U.S., Oct. 8 -- An application to own the trademark for 'TAFDRI' has been filed on Apr. 08, 2025.
Owner(s):
CivicaScript, LLC; 2912 Executive Parkway, Suite 300, , UTAH
Goods and/or Services:
For: Pharmaceutical products for the treatment of cancer; pharmaceutical products for the prevention of organ rejection in kidney transplantation; pharmaceutical products for the prevention of organ rejection in liver transplantation
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-10-07&serialNumber=99127132
Disclaimer: Curated by HT Syndication....